Goldshield Pays £4M To Settle Price-Fixing Allegations
Pharmaceutical company Goldshield Group plc has agreed to pay the United Kingdom Department of Health £4 million ($8 million) to settle claims of price-fixing, while two of the company's executives have...To view the full article, register now.
Already a subscriber? Click here to view full article